1 Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol,2010,24:555-571.
2 何煊,罗朱琳,汤善宏,等. Gilber综合征17例临床分析,中西医结合消化杂志,2015,10.
3 Kaufman SS, Wood RP, Shaw BW, et al. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology, 1986, 6:1259-1262.
4 Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinical entity with 12 cases. Medicine (Baltimore), 1954,33:155-197.
5 Sprintz H,Nelson RS. Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases. Ann Internal Med,1954,41:952-962.
6 Nies AT, Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch,2007,453:643-659.
7 Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol,2006,2:351-366.
8 Rotor AB, Manahan L, Florentin A. Familial nonhemolytic jaundice with direct van den Bergh reaction. Acta Med Phil, 1948: 5.
9 Berthelot P, Dhumeaux D. New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias. Gut,1978,19: 474-480.
10 孙永平,杜宗尧, 沈伟,等. Rotor综合征(二例肝细胞超微结构观察及发病机理的探讨). 天津医药,1981,10: 596-599+642-643.
11 Pratt E, Sissung TM, Figg WD. Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancer. Cancer Biol Ther,2012,13:1374-1375.
12 van de Steeg E1, Stráneck V, Hartmannová H,et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest,2012,122:519-528.
13 Kagawa T, Oka A, Kobayashi Y, et al. Recessive Inheritance of Population-Specific Intronic LINE-1 Insertion Causes a Rotor Syndrome Phenotype. Hum Mutat, 2015, 36:327-332.
14 吴春明,曹家麟,朱小区,等.Rotor综合征并发慢性乙型肝炎1例报告. 浙江实用医学,2011,6: 463-464.
15 孙九光,王健明. 自拟消黄降酶冲剂治疗Rotor综合征10例. 中医杂志,1998,11:676. |
